Cell Signaling Technology

NAC1 Antibody

#4420 · $317

100
Citing papers
10.5k
Combined citations
Supplier page Find this product

Research areas

NF-κB Signaling Pathways9Neurogenesis and neuroplasticity mechanisms7Neuroscience and Neuropharmacology Research6Axon Guidance and Neuronal Signaling6Melanoma and MAPK Pathways6Cytokine Signaling Pathways and Interactions5Cell death mechanisms and regulation5Ubiquitin and proteasome pathways5

Papers citing this product

1
Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome
Cancer Research·2007·671 cit.·DOI
2
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment
Cell·2023·635 cit.·DOI
3
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape
Science·2021·443 cit.·DOI
4
Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
Nature Medicine·2018·324 cit.·DOI
5
N1-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism
Nature Communications·2021·253 cit.·DOI
6
Oxidative stress disrupts oligodendrocyte maturation
Journal of Neuroscience Research·2009·239 cit.·DOI
7
Kaempferol acts through mitogen‐activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells
British Journal of Pharmacology·2011·224 cit.·DOI
8
Vav1 Transduces T Cell Receptor Signals to the Activation of Phospholipase C-γ1 via Phosphoinositide 3-Kinase-dependent and -independent Pathways
The Journal of Experimental Medicine·2002·209 cit.·DOI
9
Phosphorylation of c-Fos by Members of the p38 MAPK Family
Journal of Biological Chemistry·2005·205 cit.·DOI
10
Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma
Blood·2005·184 cit.·DOI

Similar products

ProductVendorPricePapers
NAC1 AntibodyRabbitCell Signaling Technology$317100
NAC1 Antibody — Evidence — PubIndex